alanine has been researched along with baricitinib in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 17 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barlow, A; Barlow, B; Claassen, CW; Heavner, JJ; Heavner, MS; Landolf, KM; Yeung, SYA | 1 |
| Magro, G | 1 |
| Ahuja, N; Amin, AN; Arguinchona, H; Beigel, JH; Billings, J; Bonnett, T; Branche, AR; Burgess, TH; Cantos, VD; Cardoso, A; Cohen, SH; Davey, RT; de Bono, S; Dempsey, W; Deye, GA; Dodd, LE; El Sahly, HM; Elie, MC; Engemann, JJ; Erdmann, N; Ferreira, J; Finberg, RW; Frank, M; Ghazaryan, V; Green, M; Hsieh, L; Iovine, NM; Jackson, PEH; Jain, MK; Kalil, AC; Kim, ES; Kline, S; Ko, ER; Larson, L; Luetkemeyer, AF; Lye, DC; Makowski, M; Marconi, VC; Mehta, AK; Mularski, RA; Nayak, SU; Nielsen, H; Oh, MD; Patterson, TF; Paules, CI; Ponce, PO; Proschan, M; Regalado Pineda, J; Rouphael, NG; Ruiz-Palacios, GM; Saklawi, Y; Sandkovsky, U; Sweeney, DA; Taiwo, B; Tan, SY; Tapson, V; Taylor, BS; Tomashek, KM; Watanabe, M; Wolfe, CR | 1 |
| Wen, S; Xu, X; Yadav, AK; Yu, L | 1 |
| Li, CC; Li, J; Liu, HH; Wang, J; Yin, XD | 1 |
| Cantini, F; Goletti, D | 1 |
| Hastings, R; Jha, R; Kumar, P; Quek, E; Tahir, H | 1 |
| Awano, N; Fujimoto, K; Inomata, M; Ito, Y; Izumo, T; Kuse, N; Matsumoto, H; Muto, Y; Saiki, A; Sakamoto, K; Takada, K; Tone, M | 1 |
| Adams, DH; Alatorre-Alexander, J; Cardoso, A; Chakladar, S; Crowe, B; de Bono, S; de Cassia Pellegrini, R; Ely, EW; Estrada, V; Goldman, JD; Kartman, CE; Krishnan, V; Liao, R; Marconi, VC; Piruzeli, MLB; Ramanan, AV; Reis, P; Som, M; Zhang, X | 1 |
| Ferrara, F; Vitiello, A | 2 |
| Belger, M; Burge, R; Hille, E; Kelton, K; Klein, T; McCollam, PL; Murphy, D; Spiro, T | 1 |
| Arasawa, S; Hirayama, Y; Iwashima, D; Takahashi, KI; Uemasu, K; Yasuda, Y | 1 |
| Banerjee, D; Das, D; Mukhopadhyay, P | 1 |
| Horii, H; Kamada, K; Kojima, Y; Konno, S; Matsumoto, M; Nakakubo, S; Nakamura, J; Sato, K; Shima, H; Suzuki, M; Takei, N; Yamashita, Y | 1 |
| Rochwerg, B; Tran, A | 1 |
6 review(s) available for alanine and baricitinib
| Article | Year |
|---|---|
Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019.
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azetidines; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Immunomodulation; Interferon-alpha; Lopinavir; Nelfinavir; Nitro Compounds; Pandemics; Pneumonia, Viral; Purines; Pyrazoles; Ribavirin; Ritonavir; SARS-CoV-2; Sulfonamides; Thiazoles | 2020 |
COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking.
Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Anticoagulants; Antiviral Agents; Azetidines; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Disseminated Intravascular Coagulation; Drug Combinations; Heparin; Humans; Hydroxychloroquine; Inflammation; Interleukin 1 Receptor Antagonist Protein; Lopinavir; Pandemics; Pneumonia, Viral; Purines; Pyrazoles; Ritonavir; SARS-CoV-2; Sulfonamides | 2020 |
Antiviral treatment in COVID-19: which is the most promising?-a narrative review.
Topics: Adenosine Monophosphate; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azetidines; Chloroquine; COVID-19; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferons; Ivermectin; Lopinavir; Nitro Compounds; Oseltamivir; Purines; Pyrazines; Pyrazoles; Ribavirin; Ritonavir; Sulfonamides; Thiazoles | 2021 |
COVID-19 illness and autoimmune diseases: recent insights.
Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Arthritis, Rheumatoid; Autoimmune Diseases; Azetidines; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Dendritic Cells; Humans; Immune System; Immunity, Innate; Immunization, Passive; Inflammatory Bowel Diseases; Killer Cells, Natural; Lupus Erythematosus, Systemic; Monocytes; Multiple Sclerosis; Purines; Pyrazoles; Sulfonamides | 2021 |
Treatment of COVID-19: a review of current and prospective pharmacotherapies.
Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiviral Agents; Azetidines; Colchicine; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Dexamethasone; Glucocorticoids; Humans; Immunization, Passive; Immunologic Factors; Ivermectin; Janus Kinase Inhibitors; Platelet Aggregation Inhibitors; Purines; Pyrazoles; SARS-CoV-2; Sulfonamides | 2021 |
Association and pharmacological synergism of the triple drug therapy baricitinib/remdesivir/rhACE2 for the management of COVID-19 infection.
Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antiviral Agents; Azetidines; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Disease Management; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Humans; Purines; Pyrazoles; Sulfonamides | 2022 |
3 trial(s) available for alanine and baricitinib
| Article | Year |
|---|---|
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Antiviral Agents; Azetidines; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Drug Therapy, Combination; Female; Hospital Mortality; Hospitalization; Humans; Janus Kinase Inhibitors; Male; Middle Aged; Oxygen Inhalation Therapy; Purines; Pyrazoles; Respiration, Artificial; Sulfonamides; Treatment Outcome | 2021 |
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial.
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Adult; Alanine; Antiviral Agents; Asia; Azetidines; COVID-19 Drug Treatment; Dexamethasone; Double-Blind Method; Europe; Humans; North America; Purines; Pyrazoles; SARS-CoV-2; South America; Sulfonamides; Treatment Outcome | 2021 |
In adults hospitalized with COVID-19, adding baricitinib vs. dexamethasone to remdesivir did not differ for MV-free survival.
Topics: Adenosine Monophosphate; Adult; Alanine; Azetidines; COVID-19 Drug Treatment; Dexamethasone; Double-Blind Method; Humans; Purines; Pyrazoles; Sulfonamides | 2022 |
8 other study(ies) available for alanine and baricitinib
| Article | Year |
|---|---|
An EUA for baricitinib (Olumiant) for COVID-19.
Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Antiviral Agents; Azetidines; Child; COVID-19 Drug Treatment; Drug Approval; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Purines; Pyrazoles; Randomized Controlled Trials as Topic; Sulfonamides; United States; United States Food and Drug Administration | 2020 |
Baricitinib Therapy in Covid-19 Pneumonia - An Unmet Need Fulfilled.
Topics: Adenosine Monophosphate; Adult; Alanine; Azetidines; COVID-19 Drug Treatment; Humans; Purines; Pyrazoles; SARS-CoV-2; Sulfonamides | 2021 |
Clinical impact of combination therapy with baricitinib, remdesivir, and dexamethasone in patients with severe COVID-19.
Topics: Adenosine Monophosphate; Aged; Alanine; Azetidines; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Purines; Pyrazoles; Respiration, Artificial; SARS-CoV-2; Sulfonamides; Treatment Outcome | 2021 |
Cost-Effectiveness of Combination of Baricitinib and Remdesivir in Hospitalized Patients with COVID-19 in the United States: A Modelling Study.
Topics: Adenosine Monophosphate; Alanine; Azetidines; Cost-Benefit Analysis; COVID-19 Drug Treatment; Humans; Purines; Pyrazoles; Quality-Adjusted Life Years; SARS-CoV-2; Sulfonamides; United States | 2022 |
Perspectives of association Baricitinib/Remdesivir for adults with Covid-19 infection.
Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Azetidines; COVID-19 Drug Treatment; Cytokine Release Syndrome; Drug Combinations; Humans; Immunologic Factors; Pandemics; Purines; Pyrazoles; Sulfonamides | 2022 |
Efficacy of the combination of baricitinib, remdesivir, and dexamethasone in hypoxic adults with COVID-19: A retrospective study.
Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Azetidines; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Humans; Purines; Pyrazoles; Retrospective Studies; SARS-CoV-2; Sulfonamides | 2022 |
Mortality comparision in patients receiving either Remdesivir or Remdesivir plus Baricitinib combination in case of moderate to severe COVID-19 Pneumonia: A retrospective study.
Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Azetidines; COVID-19 Drug Treatment; Humans; Purines; Pyrazoles; Retrospective Studies; SARS-CoV-2; Sulfonamides | 2022 |
Combination therapy with remdesivir and immunomodulators improves respiratory status in COVID-19: A retrospective study.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Azetidines; COVID-19 Drug Treatment; Humans; Immunologic Factors; Oxygen; Purines; Pyrazoles; Retrospective Studies; SARS-CoV-2; Sulfonamides | 2022 |